A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study

被引:0
|
作者
Haude, Michael [1 ]
Iglesias, Juan F. [2 ]
Garcia-Garcia, Hector M. [3 ]
Barlagiannis, Dimitrios [1 ]
Degrauwe, Sophie [2 ]
Melaku, Gebremedhin [3 ]
Beyene, Solomon [3 ]
Waksman, Ron [3 ]
机构
[1] Rheinland Klinikum Neuss GmbH Lukaskrankenhaus, Med Clin I, Neuss, Germany
[2] Geneva Univ Hosp, Dept Cardiol, Geneva, Switzerland
[3] MedStar Washington Hosp Ctr, Intervent Cardiol, Washington, DC USA
关键词
D O I
10.4244/EIJ-D-24-00355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e1118 / e1120
页数:3
相关论文
共 28 条
  • [1] First in human study BIOMAG-I: 12 months results of the sirolimus eluting resorbable coronary magnesium scaffold system (DREAMS 3G) in the treatment of subjects with de novo coronary artery lesions
    Haude, M.
    Wlodarczak, A.
    Van der Schaaf, R.
    Torzewski, J.
    Ferdinande, B.
    Escaned, J.
    Iglesias, J. F.
    Bennett, J.
    Toth, G.
    Joner, M.
    Toelg, R.
    Wiemer, M.
    Olivecrona, G.
    Vermeersch, P.
    Waksman, R.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [2] A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first- in-human study
    Haude, Michael
    Wlodarczak, Adrian
    Schaaf, Rene J. van der
    Torzewski, Jan
    Ferdinande, Bert
    Escaned, Javier
    Iglesias, Juan F.
    Bennett, Johan
    Toth, Gabor
    Joner, Michael
    Toelg, Ralph
    Wiemer, Marcus
    Olivecrona, Goeran
    Vermeersch, Paul
    Garcia-Garcia, Hector M.
    Waksman, Ron
    EUROINTERVENTION, 2023, 19 (05) : E414 - U80
  • [3] Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study
    Seguchi, Masaru
    Aytekin, Alp
    Xhepa, Erion
    Haude, Michael
    Wlodarczak, Adrian
    van der Schaaf, Rene J.
    Torzewski, Jan
    Ferdinande, Bert
    Escaned, Javier
    Iglesias, Juan F.
    Bennett, Johan
    Toth, Gabor G.
    Toelg, Ralph
    Wiemer, Marcus
    Olivecrona, Goeran
    Vermeersch, Paul
    Waksman, Ron
    Garcia-Garcia, Hector M.
    Joner, Michael
    EUROINTERVENTION, 2024, 20 (18)
  • [4] Optical Coherence Tomography Characteristics of the Novel Resorbable Magnesium Scaffold at 6 Months: An Intravascular Imaging Analysis of the First-in-Human Trial on DREAMS 3G
    Seguchi, Masaru
    Aytekin, Alp
    Xhepa, Erion
    Haude, Michael
    Wlodarczak, Adrian
    van der Schaaf, Rene J.
    Torzewski, Jan
    Ferdinande, Bert
    Escaned, Javier
    Iglesias, Juan F.
    Bennett, Johan
    Toth, Gabor
    Toelg, Ralph
    Wiemer, Marcus
    Olivecrona, Goran
    Verheye, Stefan
    Garcia, Hector M. Garcia
    Joner, Michael
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (04) : S75 - S75
  • [5] Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study
    Haude, Michael
    Wlodarczak, Adrian
    van der Schaaf, Rene J.
    Torzewski, Jan
    Ferdinande, Bert
    Escaned, Javier
    Iglesias, Juan F.
    Bennett, Johan
    Toth, Gabor
    Joner, Michael
    Toelg, Ralph
    Wiemer, Marcus
    Olivecrona, Goeran
    Vermeersch, Paul
    Garcia-Garcia, Hector M.
    Waksman, Ron
    ECLINICALMEDICINE, 2023, 59
  • [6] 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment
    Steiner, Sabine
    Willfort-Ehringer, Andrea
    Sievert, Horst
    Geist, Volker
    Lichtenberg, Michael
    Del Giudice, Costantino
    Sauguet, Antoine
    Diaz-Cartelle, Juan
    Marx, Claudia
    Strobel, Armin
    Schult, Ingolf
    Scheinert, Dierk
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (10) : 934 - 941
  • [7] Catheter-Based Renal Denervation for Resistant Hypertension 12-Month Results of the EnligHTN I First-in-Human Study Using a Multielectrode Ablation System
    Papademetriou, Vasilios
    Tsioufis, Costas P.
    Sinhal, Ajay
    Chew, Derek P.
    Meredith, Ian T.
    Malaiapan, Yuvi
    Worthley, Matthew I.
    Worthley, Stephen G.
    HYPERTENSION, 2014, 64 (03) : 565 - +
  • [8] TEMPORAL CHANGES IN CORONARY PLAQUE AS ASSESSED BY AN ARTIFICIAL INTELLIGENCE BASED OPTICAL COHERENCE TOMOGRAPHY (OCT): FROM THE FIRST-IN-HUMAN TRIAL ON DREAMS 3G SCAFFOLD
    Melaku, G.
    Garcia-Garcia, H.
    Levine, M.
    Beyene, S.
    Haude, M.
    Wlodarczak, A.
    Van der Schaaf, R.
    Torzewski, J.
    Ferdinande, B.
    Escaned, J.
    Iglesias, J.
    Bennett, J.
    Toth, G.
    Toelg, R.
    Wiemer, M.
    Olivecrona, G.
    Verheye, S.
    Joner, M.
    Waksman, R.
    ATHEROSCLEROSIS, 2023, 379
  • [9] Temporal changes in coronary plaque as assessed by an artificial intelligence-based optical coherence tomography: from the first-in-human trial on DREAMS 3G scaffold
    Garcia-Garcia, Hector M.
    Waksman, Ron
    Melaku, Gebremedhin D.
    Garg, Mohil
    Beyene, Solomon
    Wlodarczak, Adrian
    Kerai, Ajay
    Levine, Molly B.
    van der Schaaf, Rene J.
    Torzewski, Jan
    Ferdinande, Bert
    Escaned, Javier
    Iglesias, Juan F.
    Bennett, Johan
    Toth, Gabor G.
    Joner, Michael
    Toelg, Ralph
    Wiemer, Marcus
    Olivecrona, Goran
    Vermeersch, Paul
    Haude, Michael
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2024, 25 (04) : 491 - 497
  • [10] Endeavor I "first in human" safety and efficacy study - 12-month clinical, angiographic, and intravascular ultrasound results
    Meredith, IT
    Ormiston, J
    Whitbourn, R
    Kay, P
    Muller, D
    Popma, JJ
    Fitzgerald, P
    Kuntz, RE
    CIRCULATION, 2004, 110 (17) : 563 - 564